AstraZeneca reports total voting rights By Investing.com
AstraZeneca PLC (LSE/STO/NASDAQ:LON:), the global biopharmaceutical company, announced today that as of June 30, 2024, its issued share capital consists…
AstraZeneca to buy Pfizer’s rare disease gene therapy portfolio for up to $1 billion By Reuters
2/2 © Reuters. FILE PHOTO-Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May…
